Page last updated: 2024-09-03

ym 529 and Rheumatoid Arthritis

ym 529 has been researched along with Rheumatoid Arthritis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chikuda, H; Inoue, M; Kaneko, T; Okamura, K; Okura, C; Suto, T; Tachibana, M; Tamura, Y; Yonemoto, Y	1
Choe, H; Harigane, K; Inaba, Y; Kumagai, K; Kusayama, Y; Saito, T; Tezuka, T	1
Ebina, K; Hashimoto, J; Hirao, M; Kaneshiro, S; Noguchi, T; Yoshikawa, H; Yukioka, M	1

Trials

1 trial(s) available for ym 529 and Rheumatoid Arthritis

Article	Year
Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2018, Volume: 29, Issue:7 Topics: Administration, Oral; Aged; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Drug Administration Schedule; Female; Femur Neck; Hip Joint; Humans; Imidazoles; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Risedronic Acid	2018

Article

Year

Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2018, Volume: 29, Issue:7

Topics: Administration, Oral; Aged; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Drug Administration Schedule; Female; Femur Neck; Hip Joint; Humans; Imidazoles; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Risedronic Acid

2018

Other Studies

2 other study(ies) available for ym 529 and Rheumatoid Arthritis

Article	Year
Short-term daily teriparatide in patients with rheumatoid arthritis. Modern rheumatology, 2018, Volume: 28, Issue:3 Topics: Aged; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Osteoporosis, Postmenopausal; Teriparatide	2018
Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2016, Volume: 27, Issue:1 Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Alendronate; Arthritis, Rheumatoid; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Drug Administration Schedule; Drug Substitution; Female; Humans; Imidazoles; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Patient Preference; Prospective Studies; Risedronic Acid	2016

Article

Year

Short-term daily teriparatide in patients with rheumatoid arthritis.

Modern rheumatology, 2018, Volume: 28, Issue:3

Topics: Aged; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Osteoporosis, Postmenopausal; Teriparatide

2018

Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study.

Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Alendronate; Arthritis, Rheumatoid; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Drug Administration Schedule; Drug Substitution; Female; Humans; Imidazoles; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Patient Preference; Prospective Studies; Risedronic Acid

2016